Similar Articles
961 Sorafenib after resection improves the outcome of BCLC stage C hepatocellular carcinoma
962 High-dose hepatitis B immunoglobulin therapy in hepatocellular carcinoma with hepatitis B virus-DNA/hepatitis B e antigen-positive patients after living donor liver transplantation
963 Oncogenic Wnt3a expression as an estimable prognostic marker for hepatocellular carcinoma
964 Hepatocellular carcinoma: Review of disease and tumor biomarkers
965 Host nucleotide polymorphism in hepatitis B virus-associated hepatocellular carcinoma
966 Comprehensive treatments for hepatocellular carcinoma with tumor thrombus in major portal vein
967 Dual-input two-compartment pharmacokinetic model of dynamic contrast-enhanced magnetic resonance imaging in hepatocellular carcinoma
968 Latest developments in precancerous lesions of hepatocellular carcinoma
969 Liver transplantation for hepatocellular carcinoma beyond the Milan criteria: A review
970 Auphen and dibutyryl cAMP suppress growth of hepatocellular carcinoma by regulating expression of aquaporins 3 and 9 in vivo
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA